2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Pseudophakia: new trials by email Literature Review of Pseudophakia trials Research Report on Pseudophakia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Posterior Corneal Toricity on Refractive Outcome of Pseudophakia phacoemulsification, Pentacam (Oculus,Germany)examination - Astigmatism, Cataract | Phase 4 | Unknown | China Medical University, China | 30 | 2012-02-01 | 2012-03-15 |
| Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification Pred Forte, Lotemax - Pseudophakia, Cataract Surgery | Phase 4 | Unknown | Innovative Medical | 100 | 2010-09-01 | 2012-06-14 |
Astigmatism (1) · Cataract (1)
Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Eye Diseases (1) · Lens Diseases (1) · Refractive Errors (1)
Loteprednol Etabonate (1) · Phacoemulsification (1) · prednisolone acetate (1)
China Medical University, China (1) · Innovative Medical (1)
China (1) · United States (1)
Bonnie Henderson, MD (1) · Jinsong Zhang, MD (1) · John Hovanesian, MD (1) · William Trattler, MD (1)